Cargando…

Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID‐19

Detalles Bibliográficos
Autores principales:	Huang, Jiansheng, Huang, Hui, Wang, Dongdong, Wang, Chuan, Wang, Youfa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586990/ https://www.ncbi.nlm.nih.gov/pubmed/33135358 http://dx.doi.org/10.1002/ctm2.184

Ejemplares similares

A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
por: Wang, Yingdan, et al.
Publicado: (2022)

Correlation of vaccine‐elicited antibody levels and neutralizing activities against SARS‐CoV‐2 and its variants
por: Liu, Jinbiao, et al.
Publicado: (2021)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2
por: Speer, Claudius, et al.
Publicado: (2021)

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms
por: Billany, Roseanne E., et al.
Publicado: (2021)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant
por: Liu, Zezhong, et al.
Publicado: (2022)

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
por: Du, Shuo, et al.
Publicado: (2021)

Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
por: Lan, Jiaming, et al.
Publicado: (2018)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021)

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People
por: Saeed, Umar, et al.
Publicado: (2021)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages
por: Wang, Lei, et al.
Publicado: (2022)

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
por: Zeng, Cong, et al.
Publicado: (2021)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Structures of Omicron spike complexes and implications for neutralizing antibody development
por: Guo, Hangtian, et al.
Publicado: (2022)

A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial
por: Cao, Yu, et al.
Publicado: (2022)

Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
por: da Silva, Almir Ribeiro, et al.
Publicado: (2022)

Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
por: Weidner, Lisa, et al.
Publicado: (2021)

Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
por: Lamy, Gaspard, et al.
Publicado: (2021)

Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2
por: Tu, Danna, et al.
Publicado: (2021)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1
por: Ruan, Qiao-ling, et al.
Publicado: (2023)

A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants
por: Duan, Xiaomin, et al.
Publicado: (2022)

Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
por: Faustini, Sian, et al.
Publicado: (2022)

Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients
por: El Haggan, Wael, et al.
Publicado: (2022)

Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients
por: Chen, Jun, et al.
Publicado: (2023)

Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant
por: Yuan, Shu, et al.
Publicado: (2022)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population()
por: Camacho, Jorge, et al.
Publicado: (2023)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
por: Bi, Xiuqiong, et al.
Publicado: (2022)

Vaccination Strategies at a COVID-19 Mass Vaccination Site
por: Hsiao, Sheng-Huang, et al.
Publicado: (2022)

Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns
por: Cassaniti, Irene, et al.
Publicado: (2021)

Delta or Omicron BA.1/2‐neutralizing antibody levels and T‐cell reactivity after triple‐vaccination or infection
por: Rose, Ruben, et al.
Publicado: (2022)

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants
por: Xu, Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g1nal2c3kd2g49op5sqmjub2e6